+634.5%
MRNA vs PSKY
-75.5%
+710.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | PSKY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +1.6% | -0.8% | +0.5% |
| 7D | -8.2% | -6.0% | -2.3% | -7.4% |
| 30D | +125.6% | +10.7% | +114.9% | +123.1% |
| 3M | +197.1% | +1.2% | +195.9% | +196.9% |
| 6M | +148.5% | +1.5% | +147.0% | +148.2% |
| YTD | +363.3% | -21.8% | +385.0% | +375.3% |
| 1Y | +462.0% | -30.2% | +492.2% | +479.7% |
| 3Y | +26.9% | -20.1% | +47.0% | +25.0% |
| 5Y | -69.6% | -70.5% | +0.9% | -68.1% |
| All | +634.5% | -75.5% | +710.0% | +1,135.8% |
Cumulative growth
Daily Returns
Daily percentage return beside PSKY.
Daily Out/Under-Performance
Portfolio return minus PSKY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSKY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded PSKY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling